Estée Lauder
No proof required
Up to $5,000
Claims opening soon
A
Allergan, Senju Pharmaceutical, Kyorin Pharmaceutical
Direct purchasers of certain eye care products may have been eligible for a $9 million antitrust class action settlement.
ClosedUnited States-wideClaim status: Claim window closedPayout: Closed settlementNo longer claimable
About this settlement
Alleged antitrust violations related to the pricing and sale of Zymar and Zymaxid eye care products.
This settlement resolved claims against Allergan, Senju Pharmaceutical, and Kyorin Pharmaceutical regarding alleged antitrust violations involving eye care products Zymar and Zymaxid. The $9 million fund was for direct purchasers of these products.
Who qualifies
- Direct purchasers of Zymar or Zymaxid eye care products from Allergan, Senju Pharmaceutical, or Kyorin Pharmaceutical.
Closed settlement
Claim status: Claim window closed
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
644 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon
Apple
No proof required
Up to $100
Claims opening soon